Related Experiment Video
Updated: May 9, 2025

Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
Brain-wide microglia replacement using a nonconditioning strategy ameliorates pathology in mouse models of
Dadian Chen1, Chen Wang2, Xi Chen3
1Xiamen Key Laboratory of Brain Center, First Affiliated Hospital of Xiamen University and Fujian Provincial Key Laboratory of Neurodegenerative Disease and Aging Research, Institute of Neuroscience, School of Medicine, Xiamen University, Xiamen, Fujian 361102, China.
Abstract:
Growing genetic and pathological evidence has identified microglial dysfunction as a key contributor to the pathogenesis and progression of various neurological disorders, positioning microglia replacement as a promising therapeutic strategy. Traditional bone marrow transplantation (BMT) methods for replenishing brain microglia have limitations, including low efficiency and the potential for brain injury because of preconditioning regimens, such as irradiation or chemotherapy. Moreover, BM-derived cells that migrate to the brain do not recapitulate the phenotypic and functional properties of resident microglia. Here, we present a microglia transplantation strategy devoid of any conditioning, termed "tricyclic microglial depletion for transplantation" (TCMDT). This approach leverages three cycles of microglial depletion using the colony stimulating factor 1 receptor (CSF1R) inhibitor PLX3397, creating an optimal window for efficient engraftment of exogenous microglia. Transplantation of primary cultured microglia by TCMDT successfully restored the identity and functions of endogenous microglia. To evaluate the therapeutic potential of TCMDT, we applied this strategy to two distinct mouse models of neurologic disorder. In a Sandhoff disease model, a neurodegenerative lysosomal storage disorder caused by hexosaminidase subunit beta (Hexb) deficiency, TCMDT effectively replaced deficient microglia, attenuating neurodegeneration and improving motor performance. Similarly, in an Alzheimer's disease (AD)-related amyloid mouse model carrying the triggering receptor expressed on myeloid cells 2 (Trem2) R47H mutation, our transplantation strategy rescued microglial dysfunction and mitigated AD-related pathology. Overall, our study introduces TCMDT as a practical, efficient, and safe approach for microglia replacement, suggesting therapeutic potential for treating neurological disorders associated with microglial dysfunction.
Insights
A novel microglia transplantation method, tricyclic microglial depletion for transplantation (TCMDT), efficiently replaces dysfunctional microglia without conditioning. This approach shows therapeutic potential for neurological disorders like Sandhoff disease and Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglial dysfunction is implicated in neurological disorders.
- Traditional bone marrow transplantation for microglia replacement has limitations, including low efficiency and potential brain injury.
- Existing methods fail to fully restore resident microglia phenotype and function.
Purpose of the Study:
- To develop a novel, non-conditioning microglia transplantation strategy.
- To evaluate the efficacy and therapeutic potential of this new method in preclinical models.
Main Methods:
- Developed "tricyclic microglial depletion for transplantation" (TCMDT) using CSF1R inhibitor PLX3397.
- Transplanted primary cultured microglia into mice using TCMDT.
- Assessed microglia replacement, identity, and function in Sandhoff disease and Alzheimer's disease mouse models.
Main Results:
- TCMDT enabled efficient engraftment of exogenous microglia without preconditioning.
- Transplanted microglia restored endogenous microglial identity and function.
- TCMDT attenuated neurodegeneration in Sandhoff disease and mitigated Alzheimer's pathology.
Conclusions:
- TCMDT is a practical, efficient, and safe method for microglia replacement.
- This strategy holds therapeutic promise for neurological disorders linked to microglial dysfunction.
More Related Videos
05:35Transplantation of Human Induced Pluripotent Stem Cell-Derived Microglia in Immunocompetent Mice Brain via Non-Invasive Transnasal Route
Published on: May 31, 2022
07:54Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017